カテゴリ： GlobalData, アメリカ, 企業調査

NanoString Technologies Inc (NSTG)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：NanoString Technologies Inc (NSTG) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7857
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：77
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company’s products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways, among others. Its nCounter MAX analysis system provides cost-effective method to profile various miRNA, miRGE or DNA molecules simultaneously employing a novel digital molecular barcoding technology. The company sells its products through direct sales force and distributors in Austria, Poland, Czech Republic, Slovakia, Hungary, Croatia, Slovenia, Bosnia Herzegovina, Serbia, Romania, Albania, Macedonia and Bulgaria, among others. NanoString is headquartered in Seattle, Washington, the US.

NanoString Technologies Inc (NSTG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NanoString Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
NanoString Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
NanoString Technologies Inc, Medical Equipment, Deal Details 12
Venture Financing 12
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 13
NanoString Technologies To Raise US$0.65 Million In Venture Financing 15
Partnerships 16
NanoString Enters into Agreement with RIKEN Genesis 16
NanoString Technologies Enters into Distribution Agreement with SAM Laboratory 17
NanoString Technologies Enters into Agreement with NSABP Foundation 18
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 19
NanoString Technologies Enters into Co-Development Agreement with HalioDx 20
NanoString Technologies Enters into Agreement with Cell Signaling Technology 21
Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 22
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 24
NanoString Enters into Co-Development Agreement with MD Anderson Cancer Center 25
NanoString Enters into Research Agreement with Brigham and Women’s Hospital 26
NanoString Enters into Co-Development Agreement with Celgene 27
NanoString Technologies Enters Into Option Agreement With Broad Institute To License Liver Cancer Gene Signature 28
Equity Offering 29
NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 29
NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 31
NanoString Technologies Raises USD57.8 Million in Public Offering of Shares 32
NanoString to Raise USD40 Million in Public Offering of Shares 34
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 35
NanoString Technologies Completes IPO Of Shares For US$54 Million 37
NanoString Technologies Inc – Key Competitors 39
NanoString Technologies Inc – Key Employees 40
NanoString Technologies Inc – Locations And Subsidiaries 41
Head Office 41
Recent Developments 42
Financial Announcements 42
Aug 07, 2018: NanoString Technologies Releases Operating Results for Second Quarter of 2018 42
Jul 16, 2018: NanoString Technologies Provides Preliminary Revenue Results for Second Quarter 2018 44
May 08, 2018: NanoString Technologies Releases Operating Results for First Quarter of 2018 45
Jan 08, 2018: NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017 47
Nov 02, 2017: NanoString Technologies Releases Operating Results for Third Quarter of 2017 48
Oct 11, 2017: NanoString Announces Preliminary Revenue for Third Quarter of Fiscal Year 2017 49
Aug 08, 2017: NanoString Technologies Releases Operating Results for Second Quarter of 2017 50
May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017 51
Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook 52
Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016 53
Corporate Communications 54
Jan 16, 2018: NanoString Appoints Thomas Bailey as Chief Financial Officer 54
May 10, 2017: NanoString Appoints Elisha W. Finney to Board of Directors 55
Product News 56
May 31, 2018: NanoString Highlights Record Number of nCounter-Based Abstracts at the 2018 Annual Meeting of the American Society of Clinical Oncology 56
Dec 07, 2017: NanoString Technologies Highlights Advances in Precision Oncology at the 59th Annual Meeting of the American Society of Hematology 60
Nov 09, 2017: NanoString Highlights Record Number of nCounter-Based Research Abstracts at the 2017 Annual Meeting of the Society of Immunotherapy of Cancer (SITC) 61
Sep 18, 2017: NanoStrings Hyb & Seq Enables Liquid Biopsy by the Direct Capture and Sequencing of Cell-Free DNA 62
May 25, 2017: NanoString Highlights Record Number of nCounter-Related Research Abstracts Showcasing Advances in Precision Oncology at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) 63
Apr 03, 2017: Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors 65
Mar 29, 2017: NanoString Launches Multiple New Products at AACR 2017 to Advance Precision Oncology Research 67
Mar 27, 2017: NanoString Highlights a Record Number of nCounter-Based Research Abstracts in Precision Oncology and Predictive Biomarkers at the 2017 American Association of Cancer Research Annual Meeting 68
Mar 23, 2017: NanoString Launches New PlexSet Technology as an Alternative to qPCR for Multiplexed High-Throughput Gene Expression Studies 71
Feb 27, 2017: The Novartis Institutes for BioMedical Research and NanoString Technologies Demonstrate a Novel Approach for High-Plex 73
Feb 27, 2017: The Novartis Institutes for BioMedical Research and NanoString Technologies Demonstrate a Novel Approach for High-Plex, Spatial Profiling of Proteins Using nCounter-Based Digital Quantification at 2017 ASCO-SITC Clinical Immuno-Oncology Symposium 74
Feb 27, 2017: The Novartis Institutes for BioMedical Research and NanoString Technologies Demonstrates at 2017 ASCO-SITC Clinical Immuno-Oncology Symposium 75
Other Significant Developments 76
Jun 18, 2018: NanoString Establishes Netherlands Cancer Institute as a Center of Excellence for Digital Spatial Profiling 76
Appendix 77
Methodology 77
About GlobalData 77
Contact Us 77
Disclaimer 77

List of Tables
NanoString Technologies Inc, Medical Equipment, Key Facts, 2017 2
NanoString Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
NanoString Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Deals By Market, 2012 to YTD 2018 9
NanoString Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 13
NanoString Technologies To Raise US$0.65 Million In Venture Financing 15
NanoString Enters into Agreement with RIKEN Genesis 16
NanoString Technologies Enters into Distribution Agreement with SAM Laboratory 17
NanoString Technologies Enters into Agreement with NSABP Foundation 18
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 19
NanoString Technologies Enters into Co-Development Agreement with HalioDx 20
NanoString Technologies Enters into Agreement with Cell Signaling Technology 21
Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 22
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 24
NanoString Enters into Co-Development Agreement with MD Anderson Cancer Center 25
NanoString Enters into Research Agreement with Brigham and Women’s Hospital 26
NanoString Enters into Co-Development Agreement with Celgene 27
NanoString Technologies Enters Into Option Agreement With Broad Institute To License Liver Cancer Gene Signature 28
NanoString Technologies Completes Underwriters Exercise of Over-Allotment Option of Public offering of Shares of Shares for USD57.5 Million 29
NanoString Technologies Plans to Raise up to USD40 Million in Private Placement of Shares 31
NanoString Technologies Raises USD57.8 Million in Public Offering of Shares 32
NanoString to Raise USD40 Million in Public Offering of Shares 34
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 35
NanoString Technologies Completes IPO Of Shares For US$54 Million 37
NanoString Technologies Inc, Key Competitors 39
NanoString Technologies Inc, Key Employees 40

List of Figures
NanoString Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
NanoString Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
NanoString Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
NanoString Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
NanoString Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NanoString Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
NanoString Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NanoString Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[NanoString Technologies Inc (NSTG)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Yanmar Co Ltd：企業の戦略的SWOT分析
    Yanmar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • ICON Health & Fitness, Inc.：企業の戦略・SWOT・財務情報
    ICON Health & Fitness, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICON Health & Fitness, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Aker Solutions ASA (AKSO)：企業の財務・戦略的SWOT分析
    Aker Solutions ASA (AKSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • First Solar Inc (FSLR)-エネルギー分野：企業M&A・提携分析
    Summary First Solar, Inc. (First Solar) is a provider of photovoltaic (PV) solar energy solutions. It designs, manufactures and sells PV solar modules with an advanced thin-film semiconductor technology; and also develops, designs, constructs and sells PV solar power systems. The company uses its Cd …
  • Steris PLC：戦略・SWOT・企業財務分析
    Steris PLC - Strategy, SWOT and Corporate Finance Report Summary Steris PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • NV Nuon Energy：発電所・企業SWOT分析
    NV Nuon Energy - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Kura Oncology Inc (KURA)-製薬・医療分野：企業M&A・提携分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company which discovers and develops therapeutics for the treatment of solid tumors and blood cancers. Its lead drug candidate, Tipifarnib, an inhibitor of protein farnesylation, is a small molecule that targets oncogene …
  • Mitsubishi Research Institute Inc (3636)：企業の財務・戦略的SWOT分析
    Mitsubishi Research Institute Inc (3636) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Yes Bank Ltd：企業のM&A・事業提携・投資動向
    Yes Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Yes Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Sanofi-aventis Canada Inc-製薬・医療分野：企業M&A・提携分析
    Summary Sanofi-Aventis Canada Inc (Sanofi- Aventis), a subsidiary of Sanofi is a healthcare products provider that discovers, develops, and distributes therapeutic solutions. The company offers skin and hair care, cosmeceuticals, pain relief, health and wellness products. Its skin and hair care prod …
  • S.C. Johnson & Son Inc：戦略・SWOT・企業財務分析
    S.C. Johnson & Son Inc - Strategy, SWOT and Corporate Finance Report Summary S.C. Johnson & Son Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Burmeister & Wain Scandinavian Contractor AS-エネルギー分野：企業M&A・提携分析
    Summary Burmeister & Wain Scandinavian Contractor A/S (BWSC), a subsidiary of MESCO Denmark A/S, is a provider of tailor-made turnkey power plant solutions. It develops, operates and undertakes contracts for medium to large-scale power plants. The company handles projects for conventional fossil-fue …
  • Fortress Biotech Inc (FBIO)：製薬・医療：M&Aディール及び事業提携情報
    Summary Fortress Biotech Inc (Fortress), formerly Coronado Biosciences Inc is a biopharmaceutical company that develops and commercializes pharmaceutical and biotechnology products. The company offers products in the areas of dermatology, cancer, pain management and autoimmune diseases, among others …
  • Vanguard Natural Resources, LLC (VNRSQ)-石油・ガス分野：企業M&A・提携分析
    Summary Vanguard Natural Resources, LLC (Vanguard) is an upstream company. It acquires, produces, and develops oil and natural gas properties. The company owns Green River Basin, Permian Basin, Piceance Basin, Gulf Coast Basin, Arkoma Basin, Big Horn Basin, Williston Basin, Anadarko Basin, and Wind …
  • Vivergo Fuels Limited：企業の戦略的SWOT分析
    Vivergo Fuels Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Warpaint London plc (W7L)：企業の財務・戦略的SWOT分析
    Warpaint London plc (W7L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Biolase Inc (BIOL)：医療機器：M&Aディール及び事業提携情報
    Summary Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diod …
  • Premier Farnell Ltd：企業の戦略的SWOT分析
    Premier Farnell Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Ontario Teachers’ Pension Plan：戦略・SWOT・企業財務分析
    Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report Summary Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • HITT Contracting Inc：企業の戦略的SWOT分析
    HITT Contracting Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆